Addictive Potential: Unknown
Emergency Room Visits Yearly: Unknown
Mandatory Minimum Sentence: Unknown
Mechanism of Action: Cannabinoid receptor agonist
CP 47,497 is a cannabinoid receptor agonist drug, developed by Pfizer in the 1980s. It has analgesic effects and is used in scientific research. It is a potent CB1 agonist with a Kd of 2.1 nM. It is used in scientific research as a tool to study the cannabinoid system. The average dose is around 5-10mg smoked and the effects usually last for 4-6 hours.
CP 47,497 homologues have been found in the herbal mixture Spice. Although CP 47,497 is likely to have similar effects in humans as Δ9-tetrahydrocannabinol (Δ9-THC), the main active ingredient of marijuana, CP 47,497 and its homologues are not controlled substances in the U.S. According to the DEA (2009), “Based on the structural analysis, CP 47,497, is not categorized as a THC substance but shares some structural features common to the THC substances, such as Δ9-THC.”
CP 47,497 is a research chemical. Research chemicals are experimental chemicals that are not approved for human consumption. This is because not enough data exists currently about their side effects, adverse reactions, long term damage, addiction potential, etc. Although some people are willing to ingest research chemicals, it is not reasonable to assume that they are in any way safe to use recreationally.
CP 47,497 and Drug Tests:
CP 47,497 is a synthetic cannabinoid that currently cannot be detected with drug tests. This is because of how drug tests work. The basic concept is that your body attempts to break down any drugs you ingest. Metabolites are formed as part of this process; testing looks for the specific types of metabolites that could only occur as a result of drug taking. There is currently (as of Nov, 2009) no test that tests for the metabolites of synthetic cannabinoids. Rumor has it that scientists are developing a drug test that tests for them, although, the development and implementation process could take years.